Jeffrey Graham, MD, FRCPC | Authors

Jeffrey Graham, MD, Talks Immunotherapy Use in Frontline Non-Clear Cell RCC

March 23, 2021

CancerNetwork® sat down with Jeffrey Graham, MD, FRCPC, to discuss the effectiveness of immune checkpoint inhibitors as frontline therapy for non–clear cell renal cell carcinoma